彻底改变免疫:对mRNA疫苗技术和应用进行全面审查
Kai Yuan Leong1, Seng Kong Tham1, Chit Laa Poh2
1MyGenome, ALPS Global Holding Berhad, Kuala Lumpur, Malaysia.
Virology journal
|March 13, 2025
概括
使者RNA (mRNA) 疫苗为传统疫苗提供了强效,安全和有效的替代方案. 这项技术在COVID-19大流行期间至关重要,对未来的全球健康挑战具有重大前景.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 使者RNA (mRNA) 疫苗代表了疫苗学的重大进步,在效力,安全性和制造方面具有优势.
- mRNA疫苗技术的发展加速了,特别突出的是它在COVID-19大流行期间的关键作用.
研究的目的:
- 提供mRNA疫苗技术的全面分析,包括其结构,作用机制和制造工艺.
- 审查针对传染病的mRNA疫苗的临床进展和治疗潜力.
- 确定和讨论mRNA疫苗开发的挑战和未来方向.
主要方法:
- 审查关于mRNA疫苗技术的现有文献.
- 对mRNA疫苗的结构成分和免疫机制的分析.
- 检查制造工艺,包括基于纳米技术的输送系统,如脂质纳米粒子 (LNP).
主要成果:
- mRNA疫苗显示出高效率和安全性,具有快速开发和制造能力.
- 脂质纳米颗粒 (LNP) 的进步显著改善了mRNA疫苗的输送.
- 在针对各种传染病方面取得了临床进展,显示出了多功能性.
结论:
- mRNA疫苗是一个具有巨大潜力的转型平台,可以应对全球健康威胁.
- 克服稳定性,有针对性的交付,罕见的不良事件和公平的获取等挑战对于广泛采用至关重要.
- mRNA疫苗准备在未来的全球公共卫生中发挥关键作用.
相关概念视频
Vaccinations
43.3K
Overview
43.3K
The Central Dogma
19.7K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
19.7K
Cancer Vaccines
319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Recombinant DNA
93.0K
Overview
93.0K
Hybridoma Technology
13.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.9K


